BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10326537)

  • 1. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease.
    Elstein D; Klutstein MW; Lahad A; Abrahamov A; Hadas-Halpern I; Zimran A
    Lancet; 1998 May; 351(9115):1544-6. PubMed ID: 10326537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher.
    Belmatoug N; Launay O; Carbon C
    Lancet; 1998 Jul; 352(9123):240. PubMed ID: 9683246
    [No Abstract]   [Full Text] [Related]  

  • 3. Subtotal splenectomy for Gaucher's disease: a follow-up study.
    Morgenstern L; Verham R; Weinstein I; Phillips EH
    Am Surg; 1993 Dec; 59(12):860-5. PubMed ID: 8256944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in Gaucher's disease.
    Pastores GM; Miller A
    Lancet; 1998 Aug; 352(9127):580. PubMed ID: 9716094
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher's disease with mitral and aortic involvement: echocardiographic findings.
    Saraçlar M; Atalay S; Koçak N; Ozkutlu S
    Pediatr Cardiol; 1992 Jan; 13(1):56-8. PubMed ID: 1736272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should repeated partial splenectomy be attempted in patients with hematological diseases? Technical pitfalls and causes of failure in Gaucher's disease.
    Freud E; Cohen IJ; Neuman M; Mor C; Zer M
    J Pediatr Surg; 1997 Sep; 32(9):1272-6. PubMed ID: 9314241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung involvement and enzyme replacement therapy in Gaucher's disease.
    Goitein O; Elstein D; Abrahamov A; Hadas-Halpern I; Melzer E; Kerem E; Zimran A
    QJM; 2001 Aug; 94(8):407-15. PubMed ID: 11493717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.
    Mistry PK; Sirrs S; Chan A; Pritzker MR; Duffy TP; Grace ME; Meeker DP; Goldman ME
    Mol Genet Metab; 2002; 77(1-2):91-8. PubMed ID: 12359135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacement.
    Lebel E; Elstein D; Hain D; Hadas-Halpern I; Zimran A; Itzchaki M
    Isr Med Assoc J; 2003 Aug; 5(8):595-6. PubMed ID: 12929302
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement.
    Martinez Odrizola P; Ferrero O; Jauregui I; Miguel F
    Respir Med; 1998 Dec; 92(12):1370-2. PubMed ID: 10197233
    [No Abstract]   [Full Text] [Related]  

  • 14. Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.
    Perel Y; Bioulac-Sage P; Chateil JF; Trillaud H; Carles J; Lamireau T; Guillard JM
    Pediatrics; 2002 Jun; 109(6):1170-3. PubMed ID: 12042560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease.
    Bakst AE; Gaine SP; Rubin LJ
    Chest; 1999 Oct; 116(4):1127-9. PubMed ID: 10531185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-brain natriuretic peptide: correlation with tricuspid insufficiency in Gaucher disease.
    Elstein D; Nir A; Klutstein M; Abrahamov A; Zimran A
    Pulm Pharmacol Ther; 2004; 17(5):319-23. PubMed ID: 15477128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of ten years' echocardiographic follow-up in children with Gaucher disease.
    Rosengarten D; Abrahamov A; Nir A; Farber B; Glaser J; Zimran A; Elstein D
    Eur J Pediatr; 2007 Jun; 166(6):549-51. PubMed ID: 16941127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.
    Banjar H
    Ann Trop Paediatr; 1998 Mar; 18(1):55-9. PubMed ID: 9692003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.